##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 65 Download : 63

##plugins.themes.academic_pro.article.main##

Abstract

The criteria for risk stratification of the formation of diabetic foot syndrome in patients with diabetes mellitus based on the carriage of the interleukin 6 gene were studied. The clinical group included 96 patients aged 40 to 75 years with diabetes mellitus complicated by diabetic foot syndrome. The control group consisted of 83 healthy individuals. The results obtained by the authors demonstrate that the presence of the C/G genotype of the C174G polymorphism of the IL6 gene has a clear correlation with predisposition to the development of diabetic foot syndrome. In order to effectively prevent the development of diabetic foot syndrome, it is advisable to recommend genotyping of the C174G polymorphism in the IL6 gene

Keywords

Diabetic Foot Gene Polymorphism Diabetes Mellitus

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Dadabaev Omonjon Talibzhanovich. (2023). Studying the C174g Polymorphism of The Il6 Gene in the Formation of Diabetic Foot Syndrome in Patients with Diabetes Mellitus. Texas Journal of Medical Science, 25, 24–27. https://doi.org/10.62480/tjms.2023.vol25.pp24-27
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Akbari M. and Hassan-Zadeh V. (2018) IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology 26, 685–698 10.1007/s10787-018-0458-0
  2. Chang W.T., Huang M.C., Chung H.F. et al.. (2016) Interleukin-6 gene polymorphisms correlate with the progression of nephropathy in Chinese patients with type 2 diabetes: A prospective cohort study. Diabetes Res. Clin. Pract. 120, 15–23 10.1016/j.diabres.2016.07.013
  3. Chen B., Wu M., Zang C. et al.. (2019) Association Between IL-6 Polymorphisms and Diabetic Nephropathy Risk: A Meta-analysis. Am. J. Med. Sci. 358, 363–373 10.1016/j.amjms.2019.07.011
  4. Dadabaev O.T., Aleinik V.A., Musashaihov H.T., Vasilevskiy E.A. Prognostic significance of VEGFA and IL6 gene polymorphism in diabetic foot syndrome //JournalNX- A Multidisciplinary Peer Reviewed Journal. – 2022.
  5. – №11(8). – P. 279-285.
  6. Dhamodharan U., Viswanathan V., Krishnamoorthy E. et al.. (2015) Genetic association of IL-6, TNF-alpha and SDF-1 polymorphisms with serum cytokine levels in diabetic foot ulcer. Gene 565, 62–67 10.1016/j.gene.2015.03.063
  7. Ellingsgaard H., Hauselmann I., Schuler B. et al.. (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat. Med. 17, 1481–1489 10.1038/nm.2513
  8. Guariguata L., Whiting D.R., Hambleton I. et al. (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 103, 137–149 10.1016/j.diabres.2013.11.002
  9. Henning R.J. (2018) Type-2 diabetes mellitus and cardiovascular disease. Fut. Cardiol. 14, 491–509 10.2217/fca-2018-0045
  10. Hui P., Jia S., Ma W. et al.. (2015) The changes and significance of IL-6 levels in patients with OSAHS associated Type 2 diabetes Mellites. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 29, 1726–1728
  11. Ishihara K. and Hirano T. (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13, 357–368 10.1016
  12. Mathers C.D. and Loncar D. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, e442 10.1371/journal.pmed.0030442
  13. Mysliwska J., Zorena K., Mysliwiec M. et al.. (2009) The -174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus. Pediatr. Res. 66, 341–345 10.1203/PDR.0b013e3181b1bd05
  14. Nadeem A., Mumtaz S., Naveed A.K. et al.. (2017) Association of IL-6 C-174G (rs 1800795) single nucleotide polymorphism with type 2 diabetes mellitus in Pakistani population. J. Pak. Med. Assoc. 67, 428–433
  15. Paine S.K., Sen A., Choudhuri S. et al.. (2012) Association of tumor necrosis factor alpha, interleukin 6, and interleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects. Retina 32, 1197–1203 10.1097/IAE.0b013e31822f55f3
  16. Ururahy M.A., de Souza K.S., Oliveira Y.M. et al.. (2015) Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio. Diabetes Metab. Res. Rev. 31, 500–506 10.1002/dmrr.2621